CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround
24th October 2025 Uncategorised 0A cystic fibrosis buyers group has resurfaced in a bid to improve access to Vertex’s expensive combination therapy Trikafta. Under the strategy, a much cheaper copycat of the modulator drug is slated to launch next spring and will be manufactured by Bangladeshi drugmaker Beximco.
More: CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround
Source: fierce